{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:30:48Z","timestamp":1792787448143,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Acorda Therapeutics, Inc","id":[{"id":"https:\/\/ror.org\/01788sq40","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Acorda Therapeutics, Inc","id":[{"id":"https:\/\/ror.org\/01788sq40","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Acorda Therapeutics, Inc","id":[{"id":"https:\/\/ror.org\/01788sq40","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.parkreldis.2019.03.026","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T11:30:05Z","timestamp":1553945405000},"page":"175-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease"],"prefix":"10.1016","volume":"64","author":[{"given":"Robert A.","family":"Hauser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart H.","family":"Isaacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Ellenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth E.","family":"Safirstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6995-8936","authenticated-orcid":false,"given":"Daniel D.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F.","family":"Komjathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deena M.","family":"Kegler-Ebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.parkreldis.2019.03.026_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2012.03866.x","article-title":"Summary of the recommendations of the EFNS\/MDS-ES review on therapeutic management of Parkinson's disease","volume":"20","author":"Ferreira","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2019.03.026_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000131893","article-title":"Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments","volume":"60","author":"Encarnacion","year":"2008","journal-title":"Eur. Neurol."},{"issue":"21 Suppl 4","key":"10.1016\/j.parkreldis.2019.03.026_bib3","first-page":"S1","article-title":"The scientific and clinical basis for the treatment of Parkinson disease","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"issue":"Suppl 11","key":"10.1016\/j.parkreldis.2019.03.026_bib4","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1002\/mds.20458","article-title":"Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations","volume":"20","author":"Jankovic","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.03.026_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.02.001","article-title":"The spectrum of \"off\" in Parkinson's disease: what have we learned over 40 years?","volume":"51","author":"Chou","year":"2018","journal-title":"Park. Relat. Disord."},{"issue":"29\u201337","key":"10.1016\/j.parkreldis.2019.03.026_bib6","article-title":"The on-off phenomenon","author":"Lees","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry Suppl"},{"issue":"2","key":"10.1016\/j.parkreldis.2019.03.026_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mds.20279","article-title":"Impact of the motor complications of Parkinson's disease on the quality of life","volume":"20","author":"Chapuis","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.03.026_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/JPRLS.S83276","article-title":"Morning akinesia in Parkinson's disease: challenges and solutions","volume":"6","author":"Tambasco","year":"2016","journal-title":"J. Park. Restless Legs Syndrome"},{"key":"10.1016\/j.parkreldis.2019.03.026_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2016.02.066","article-title":"The impact of early morning off in Parkinson's disease on patient quality of life and caregiver burden","volume":"364","author":"Onozawa","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.parkreldis.2019.03.026_bib10","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.parkreldis.2014.09.013","article-title":"Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: an international multicenter study","volume":"20","author":"Rizos","year":"2014","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2019.03.026_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mds.26082","article-title":"Levodopa therapy for Parkinson's disease: pharmacokinetics and pharmacodynamics","volume":"30","author":"LeWitt","year":"2015","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2019.03.026_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002826-198403000-00002","article-title":"Pharmacokinetics of levodopa","volume":"7","author":"Nutt","year":"1984","journal-title":"Clin. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.parkreldis.2019.03.026_bib13","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/mds.26611","article-title":"A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease","volume":"31","author":"LeWitt","year":"2016","journal-title":"Mov. Disord."},{"issue":"360","key":"10.1016\/j.parkreldis.2019.03.026_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad8858","article-title":"Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson's disease","volume":"8","author":"Lipp","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.parkreldis.2019.03.026_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(18)30405-8","article-title":"Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial","volume":"18","author":"LeWitt","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2019.03.026_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000215875","article-title":"Levodopa: past, present, and future","volume":"62","author":"Hauser","year":"2009","journal-title":"Eur. Neurol."},{"issue":"8","key":"10.1016\/j.parkreldis.2019.03.026_bib17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/00912700022009585","article-title":"Variable absorption of carbidopa affects both peripheral and central levodopa metabolism","volume":"40","author":"Durso","year":"2000","journal-title":"J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.parkreldis.2019.03.026_bib18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2019.03.026_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"12","key":"10.1016\/j.parkreldis.2019.03.026_bib20","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.parkreldis.2019.03.026_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002826-200003000-00003","article-title":"A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia","volume":"23","author":"Hauser","year":"2000","journal-title":"Clin. Neuropharmacol."},{"issue":"Suppl 10","key":"10.1016\/j.parkreldis.2019.03.026_bib22","article-title":"Rapid levodopa augmentation following inhaled CVT-301 results in rapid improvement in motor response when administered to PD patients in the \u201coff\u201d state","volume":"82","author":"Freed","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2019.03.026_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/mdc3.12350","article-title":"Apomorphine subcutaneous injection for the management of morning akinesia in Parkinson's disease","volume":"4","author":"Isaacson","year":"2017","journal-title":"Mov Disord Clin Pract"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019301920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019301920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:17:04Z","timestamp":1761178624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802019301920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":23,"alternative-id":["S1353802019301920"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.03.026","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}